NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 72 filers reported holding NEXTCURE INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $86,000 | -41.1% | 31,298 | +1.0% | 0.03% | -43.8% |
| Q2 2022 | $146,000 | -2.0% | 30,999 | +1.3% | 0.05% | -5.9% |
| Q1 2022 | $149,000 | -19.9% | 30,591 | -1.4% | 0.05% | -21.5% |
| Q4 2021 | $186,000 | -10.6% | 31,027 | +0.3% | 0.06% | 0.0% |
| Q3 2021 | $208,000 | -17.5% | 30,927 | -1.4% | 0.06% | -24.4% |
| Q2 2021 | $252,000 | -17.6% | 31,355 | +2.5% | 0.09% | -18.9% |
| Q1 2021 | $306,000 | -7.3% | 30,603 | +1.0% | 0.11% | +10.4% |
| Q4 2020 | $330,000 | – | 30,292 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 1,581,311 | $4,186,000 | 0.48% |
| Sofinnova Investments, Inc. | 2,671,856 | $7,348,000 | 0.43% |
| Long Focus Capital Management, LLC | 556,105 | $1,529,000 | 0.15% |
| DAFNA Capital Management LLC | 187,696 | $516,000 | 0.14% |
| Orbimed Advisors | 2,711,013 | $7,455,000 | 0.14% |
| Sio Capital Management, LLC | 130,000 | $358,000 | 0.11% |
| FNY Investment Advisers, LLC | 48,000 | $132,000 | 0.09% |
| Privium Fund Management (UK) Ltd | 24,400 | $67,000 | 0.08% |
| Minerva Advisors LLC | 31,713 | $87,000 | 0.07% |
| Krensavage Asset Management, LLC | 31,298 | $86,000 | 0.03% |